57574-09-1O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21ONNOFKFOZAJDHT-UHFFFAOYSA-NAmineptine is a carbocyclic fatty acid that is 5-aminoheptanoic acid in which one of the hydrogens attached to the nitrogen is replaced by a 10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl group. A tricyclic antidepressant, it was never approved in the US and was withdrawn from the French market in 1999 due to concerns over abuse, dependence and severe acne. It has a role as an antidepressant and a dopamine uptake inhibitor. It is an amino acid, a carbocyclic fatty acid, a carbotricyclic compound and a secondary amino compound. It derives from a hydride of a dibenzo[a,d][7]annulene.
57574-09-1DTXSID1048831CHEMBL418995CHEBI:32499DEA Schedule I Controlled Substance -> Stimulants
Pharmaceuticals -> Listed in ZINC15
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Drug Induced Liver Injury Rank (DILIrank 2.0)
Amineptine
vMost-DILI-concern
8
Withdrawn
DOI:10.1016/j.drudis.2016.02.015
N - Nervous system
QN - Nervous system
Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
現在のフィルター条件では反応記録がありません。
読み込み中…